Does alcohol use provoke relapse in patients with opioid use disorder stabilized on naltrexone?

被引：0
|
作者：
Palatkin, V. [1 ]
Krupitsky, E. [2 ]
Blokhina, E. [3 ]
Verbitskaya, E. [4 ]
Zvartau, E. [5 ]
Woody, G. [6 ]
机构：
[1] First Pavlov State Med Univ, Valdman Inst Pharmacol, St Petersburg, Russia
[2] Bekhterev Natl Med Res Ctr Psychiat & Neurol, Dept Addict, St Petersburg, Russia
[3] First Pavlov State Med Univ St Petersburg, Lab Clin Psychopharmacol Addict, St Petersburg, Russia
[4] First Pavlov State Med Univ St Petersburg, Pharmacoepidemiol & Biostat, St Petersburg, Russia
[5] First Pavlov State Med Univ St Petersburg, Valdman Inst Pharmacol, St Petersburg, Russia
[6] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.455
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.443
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [41] EXPLORE THE ASSOCIATION OF SWEET PREFERENCE WITH THE TREATMENT RESPONSE TO NALTREXONE IN PATIENTS WITH ALCOHOL USE DISORDER
    Chang, Min Chiao
    Meng, Shih-Chun
    Huang, Ming-Chyi
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i298 - i299
  • [42] Injectable Extended-Release Naltrexone Effective for Opioid Use Disorder
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (12) : 819 - 819
  • [43] Association between hazardous alcohol use and initiation of naltrexone treatment for opioid use disorder among hiv-positive persons in russia
    Vetrova, M.
    Blokhina, E. A.
    Cheng, D. M.
    Truong, V.
    Quinn, E. K.
    Gnatienko, N.
    Bushara, N. M.
    Palatkin, V. Y.
    Vasilyeva, J. V.
    Yaroslavtseva, T. S.
    Krupitsky, E. M.
    Lioznov, D. A.
    Samet, J. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S228 - S229
  • [44] Follow-up of serum naltrexone levels after naltrexone implant in Opioid Use Disorder
    Kulaksizoglu, Burak
    Erdogan, Ali
    Cinemre, Buket
    Topcuoglu, Muge
    Coskun, Mustafa Nogay
    Ozdemir, Mehmet
    Bingol, Mert Sinan
    Kuloglu, Mehmet Murat
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2021, 23 (03) : 23 - 28
  • [45] A study of predictors of retention to naltrexone maintenance therapy in patients with opioid use disorder: a prospective study
    Lone, Burhan Bashir
    Jan, Neelofer
    Kousar, Muntaqueem Ul
    Bhat, Fazle Roub
    Rather, Yasir Hassan
    Rasool, Ubaid
    MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH, 2024, 31 (01):
  • [46] Remission rates of patients with opioid use disorder who got naltrexone implantation: A retrospective study
    Danisman, Mustafa
    Aydin, Seyit Murat
    Ispir, Gamze Zengin
    Katar, Kuebra Sezer
    Kurtoglu, Mustafa Batuhan
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2024, 26
  • [47] Education Intervention to Increase Naltrexone Use Among Adult Inpatients With Alcohol Use Disorder
    Ipsarides, Jason
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2023, 61 (09) : 10 - 14
  • [48] NALTREXONE PLUS KETAMINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Levy, L.
    Jane, J. S.
    Krystal, J. H.
    Petrakis, I. L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 236A - 236A
  • [49] A RESIDENT INITIATIVE TO INCREASE USE OF NALTREXONE FOR ALCOHOL USE DISORDER AT A SAFETY NET HOSPITAL
    Otto, Maria E.
    Hom, Jeffrey K.
    Shah, Shilpa M.
    Young, Natalie C.
    Fisher, Weston S.
    Pierluissi, Edgar
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S13 - S14
  • [50] 'Use of Naltrexone in treating opioid use disorder in pregnancy' (vol 222, pg 83, 2020)
    V. Towers, Craig
    Katz, Emily
    Weitz, Beth
    Visconti, Kevin
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (06) : 770 - 770
12345